[Moclobemide in the treatment of depression--an overview].


Moclobemide, a benzamidederivate, is a reversible, selective MAOI with a predominant effect upon MAO-A. In clinical trials with moclobemide so far no clearcut tyramine interaction leading to a hypertensive crisis has been reported and no case of hepatotoxicity has been observed. Open and double-blind studies have shown moclobemide to be an activating… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.